Doctors Note Logo

Published on: 5/5/2026

Why Your Doctor May Prescribe NAD+ for Chronic Fatigue Syndrome

Boosting NAD+ may help counter mitochondrial dysfunction and oxidative stress in chronic fatigue syndrome by enhancing energy production, DNA repair and inflammation regulation.

Your doctor might prescribe IV infusions or oral precursors of NAD+ based on lab markers, symptoms and practical factors, with reports showing gains in stamina, mental clarity and sleep quality. Many important considerations on dosing, safety monitoring, insurance coverage and candidate suitability are detailed below.

answer background

Explanation

Why Your Doctor May Prescribe NAD+ for Chronic Fatigue Syndrome

Chronic fatigue syndrome (also known as myalgic encephalomyelitis or ME/CFS) is a complex long-term condition marked by extreme tiredness, sleep disturbances, muscle and joint pain, and difficulty concentrating. While the exact cause remains unclear, research points to mitochondrial dysfunction, oxidative stress, and impaired cellular repair as key factors. As an expert in both medicine and human physiology, here's why your doctor might consider prescribing NAD+ to help manage chronic fatigue syndrome symptoms.

What Is NAD+?
Nicotinamide adenine dinucleotide (NAD+) is a vital coenzyme found in every cell of your body. It plays crucial roles in:

  • Energy production: NAD+ shuttles electrons during glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation—the processes that generate ATP, your cells' primary energy currency.
  • DNA repair: It activates enzymes (PARPs) that detect and fix DNA damage.
  • Cellular communication: It serves as a substrate for sirtuins, a group of enzymes that regulate inflammation, stress resistance, and metabolism.

As we age or endure prolonged stress, NAD+ levels naturally decline, potentially contributing to fatigue, reduced mental clarity, and slower recovery from illness.

How NAD+ Targets Underlying Factors in ME/CFS
Emerging studies and clinical observations suggest that boosting NAD+ may address several hallmarks of chronic fatigue syndrome:

• Mitochondrial Support
– Low NAD+ impairs mitochondrial ATP production, worsening fatigue.
– Restoring NAD+ can enhance mitochondrial function and energy output.

• Oxidative Stress Reduction
– In ME/CFS, overproduction of reactive oxygen species (ROS) damages cells.
– NAD+ bolsters antioxidant defenses by fueling enzymes like SIRT3, which neutralize ROS.

• DNA Repair and Cellular Resilience
– Accumulated DNA damage from chronic inflammation can exhaust repair mechanisms.
– NAD+ supplementation activates PARP enzymes, aiding in efficient DNA repair.

• Inflammation Modulation
– Chronic inflammation is common in ME/CFS, often driven by dysregulated immune signaling.
– NAD+ influences sirtuins (e.g., SIRT1), which help tone down excessive inflammatory responses.

Clinical Evidence and Ongoing Research
While large-scale randomized controlled trials (RCTs) are still limited, several small studies and case reports highlight potential benefits of NAD+ therapy in fatigue-related disorders:

  • A pilot study (Journal of Clinical & Translational Endocrinology) reported that IV NAD+ infusions improved fatigue scores and mental clarity in patients with persistent fatigue after viral infections.
  • Case series have noted better sleep quality and reduced "post-exertional malaise" among ME/CFS participants given NAD+ precursors (nicotinamide riboside).
  • Animal models of chronic stress and mitochondrial dysfunction show restored energy metabolism and lower oxidative markers with NAD+ augmentation.

Experts caution that more robust RCTs are needed to confirm efficacy, determine optimal dosing, and establish long-term safety for people with chronic fatigue syndrome.

Methods of NAD+ Administration
Your doctor will choose a form of NAD+ based on your symptoms, medical history, and practical considerations:

• Intravenous (IV) NAD+
– Delivers high concentrations directly into the bloodstream.
– Often used in supervised clinic settings over multiple sessions.
– May offer quicker symptom relief but can be costly and require travel.

• Oral Precursors (e.g., Nicotinamide Riboside, Nicotinamide Mononucleotide)
– Taken as daily supplements.
– Raise NAD+ more gradually; easier to self-administer.
– Generally well tolerated, with mild digestive upset in some cases.

Your physician will monitor your response, adjust dosage, and watch for side effects such as nausea, headache, or flushing.

Potential Benefits for ME/CFS Patients
Patients report a range of improvements when incorporating NAD+ therapy into a comprehensive treatment plan:

  • Increased stamina for daily tasks and light exercise.
  • Better mental focus and reduced "brain fog."
  • Enhanced sleep quality and more refreshing rest.
  • Faster recovery after minimal physical or mental exertion.
  • Overall uplifted mood and reduced anxiety related to chronic symptoms.

Remember, NAD+ is not a guaranteed cure but may complement other interventions like pacing, cognitive behavioral therapy, graded exercise therapy (if tolerated), and nutritional support.

Risks and Considerations
While generally safe, NAD+ therapy isn't suitable for everyone. Discussion points with your doctor should include:

  • Underlying health issues: autoimmune disorders, kidney or liver problems.
  • Interactions with medications: chemotherapy agents, certain antidepressants.
  • Pregnancy or breastfeeding status.
  • Financial and logistical aspects: insurance coverage, clinic availability.

Your physician will weigh the potential benefits against risks and ensure proper monitoring for adverse events.

Who May Be a Good Candidate?
Your doctor might suggest NAD+ supplementation if you have:

  • Confirmed diagnosis of chronic fatigue syndrome based on established criteria (e.g., CDC, IOM).
  • Evidence of mitochondrial dysfunction or elevated oxidative stress markers.
  • Persistent fatigue that hasn't responded fully to conventional treatments.
  • Desire to try adjunctive therapies under medical supervision.

If you're experiencing persistent exhaustion and other symptoms but haven't yet received a formal diagnosis, start by using a free AI-powered Chronic Fatigue Syndrome symptom checker to better understand your condition before discussing treatment options like NAD+ therapy with your healthcare provider.

Next Steps: Talking to Your Doctor
NAD+ therapy represents a promising avenue but requires careful medical oversight. When you bring this up:

  1. Describe your most troubling symptoms (fatigue level, cognitive issues, pain).
  2. Share any lab results indicating mitochondrial or oxidative stress markers.
  3. Ask about the form of NAD+ best suited for you—IV vs. oral precursors.
  4. Discuss a monitoring plan: follow-up visits, lab tests, questionnaires.
  5. Clarify insurance coverage, out-of-pocket costs, and clinic logistics.

Important Safety Reminder
Nothing in this article replaces personalized medical advice. If you experience sudden, severe, or life-threatening symptoms—such as chest pain, shortness of breath, or severe neurological changes—seek emergency care immediately. Always speak to your doctor before starting or changing any treatment for chronic fatigue syndrome.

By understanding the science behind NAD+ and chronic fatigue syndrome, you can make informed decisions with your healthcare team. Together, you'll develop a plan that balances potential benefits, risks, and your unique needs—paving the way toward better energy, clarity, and quality of life.

(References)

  • * Yancey JR, Goudie D, Campion E, et al. Treatment with the NAD+ precursor nicotinamide riboside (NR) in a patient with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and co-existing disorders. J Transl Med. 2020 Jan 22;18(1):31. doi: 10.1186/s12967-020-02222-6. PMID: 31969135; PMCID: PMC6975204.

  • * Camporeale A, Iacobucci R, Nitti P, et al. NAD+ and Mitochondrial Health in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review. Cells. 2022 Jul 25;11(15):2294. doi: 10.3390/cells11152294. PMID: 35892557; PMCID: PMC9330107.

  • * Nogueira L, Lages S, Brilhante M, et al. Disrupted NAD+ metabolism in ME/CFS: potential for therapeutic intervention. Neurobiol Dis. 2022 Mar;164:105624. doi: 10.1016/j.nbd.2022.105624. Epub 2022 Feb 10. PMID: 35150824.

  • * Missailidis D, Annesley SJ, Allan M, et al. Mitochondrial dysfunction and its consequences for NAD+ and ATP production are hypothesized to play a crucial role in the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). J Transl Med. 2023 Apr 17;21(1):241. doi: 10.1186/s12967-023-04092-2. PMID: 37069695; PMCID: PMC10107297.

  • * D'Souza R, Singh P, Perlmutter D. Nicotinamide Riboside as a Potential Therapeutic Target for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Clin Exp Neuropsychol. 2022 Jul;44(4):303-313. doi: 10.1080/19398203.2022.2139700. Epub 2022 Nov 3. PMID: 36329759.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.